Rodney W. Lappe, Director at Design Therapeutics, Inc. (DSGN), bought 15,000 shares at $7.96 ($119K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |